"Neuromuscular Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.
Descriptor ID |
D009465
|
MeSH Number(s) |
D27.505.696.663.700
|
Concept/Terms |
Neuromuscular Effect- Neuromuscular Effect
- Effect, Neuromuscular
- Neuromuscular Effects
- Effects, Neuromuscular
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Agents".
This graph shows the total number of publications written about "Neuromuscular Agents" by people in this website by year, and whether "Neuromuscular Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2011 | 0 | 2 | 2 |
2012 | 1 | 0 | 1 |
2013 | 2 | 0 | 2 |
2014 | 2 | 2 | 4 |
2015 | 2 | 1 | 3 |
2017 | 1 | 0 | 1 |
2020 | 3 | 0 | 3 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuromuscular Agents" by people in Profiles.
-
Botulinum Toxin Injection for the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021 12; 128(12):1766-1776.
-
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines. J Drugs Dermatol. 2020 10 01; 19(10):985-991.
-
Botulinum Toxin for the Treatment of Intractable Raynaud Phenomenon. J Hand Surg Am. 2021 Jan; 46(1):54-59.
-
The Role of Radiation Therapy and Botulinum Toxin Injections in the Management of Sialorrhea in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review. J Clin Neuromuscul Dis. 2020 Jun; 21(4):205-221.
-
Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children. J Pediatr. 2018 03; 194:241-243.
-
New treatments for incontinence. Adv Chronic Kidney Dis. 2015 Jul; 22(4):279-88.
-
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2016 06; 35(5):595-600.
-
Multiple good options are available for achalasia management. J Clin Gastroenterol. 2015 Mar; 49(3):194-8.
-
Anterocollis and anterocaput. Clin Neurol Neurosurg. 2014 Dec; 127:44-53.
-
Pyridostigmine for reversal of severe sequelae from botulinum toxin injection. J Voice. 2014 Nov; 28(6):830-4.